等待开盘 11-14 09:30:00 美东时间
+0.020
+0.03%
今日重点评级关注:摩根大通:维持CytomX Therapeutics"超配"评级,目标价从11美元升至12美元;康托·菲茨杰拉德:维持Exodus Movement"超配"评级,目标价从15美元升至16美元
11-13 11:50
今日重点评级关注:韦德布什:维持Cullinan Therapeutics"跑赢大市"评级,目标价从42美元升至44美元;HC Wainwright & Co.:维持WhiteFiber"买入"评级,目标价从34美元升至36美元
11-12 19:19
11月12日,Nutrien Ltd.(NTR)收跌0.72%,报71.65美元,成交额6726.84万美元,市值339.71亿美元。 行情数据 • 开盘价:...
11-12 05:40
今日重点评级关注:摩根士丹利:维持Riot Platforms"超配"评级,目标价从35.5美元升至41美元;Canaccord Genuity:维持塞德斯医疗"买入"评级,目标价从60美元升至68美元
11-10 18:30
JP Morgan analyst Jeffrey Zekauskas maintains Nutrien (NYSE:NTR) with a Overweight and raises the price target from $75 to $80.
11-10 04:44
数据显示,农产品股ETF前十大重仓股合计占基金资产的66.7647%。 其中,第一大重仓股为迪尔股份有限公司,持仓占比30.8141%;第二大重仓股为VYLR...
11-07 07:19
Nutrien shares are trading lower after the company reported worse-than-expected Q3 adjusted EPS results.
11-06 06:33
11月5日,Nutrien Ltd.(NTR)收涨3.97%,报72.07美元,成交额2.35亿美元,市值343.93亿美元。 行情数据 • 开盘价:69.4...
11-05 05:40
Nutrien (NYSE:NTR) reported quarterly earnings of $0.61 per share which missed the analyst consensus estimate of $0.84 by 28.24 percent. This is a 37.11 percent decrease over earnings of $0.97 per share from the same period last year. The company reported quarterly sales of $6.064 billion which beat...
11-05 05:34
11月3日,Nutrien Ltd.(NTR)收涨1.12%,报70.2美元,成交额1.21亿美元,市值335亿美元。 行情数据 • 开盘价:69.17美元 ...
11-03 05:40